Psychopharmacological therapy positively modulates disease activity in inflammatory bowel disease: a systematic review
When PCPs stay current with new medications and understand eligibility criteria beyond a diabetes diagnosis, patients can access treatments that work more quickly
Schmidt PT, Ljung T, Hartmann B, Hare KJ, Holst JJ, Hellstrm PM (2005) Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY
Using this information, health plans and PBMs can target individual providers with educational outreach on prescription benefits
Drinking a lot is bad for your body
Subsequent studies revealed that non-parenchymal cells regulate liver regeneration